MarketLens MarketLens
US: 2026-08-12 NSE: 2026-08-12 2026-08-12
Neutral
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

RIGL Rigel Pharmaceuticals, Inc.

TradingView As Of 8/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
42.1200
Day %
1.24%
RS
81
Ind Rank
#51
RS 1D
81
RS 1W
82
RS 1M
82
RS 3M
42
RS 6M
57
Consensus Rating
Buy
Current Quarter EPS
0.86
Next Quarter EPS
1.10
Current Year EPS
4.25
Next Year EPS
3.73
ExchangeUS
Market Cap0 B
52W High49.9600
From 52W High-15.69%
Open42.0000
High42.9900
Low42.0000
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-08-11
Bars Available310
Scanner Hits7
Last Scanner Hit2026-08-11

Recent Scanner History

7 matching / 7 total
Reset
Date Scanner RS
2026-08-11 Extreme Contraction
US_EXTREME_CONTRACTION
81
2026-08-04 4% Breakout
US_FOUR_PERCENT_BREAKOUT
76
2026-07-14 Extreme Contraction
US_EXTREME_CONTRACTION
82
2026-07-10 Extreme Contraction
US_EXTREME_CONTRACTION
84
2026-07-08 Extreme Contraction
US_EXTREME_CONTRACTION
86
2026-07-02 Extreme Contraction
US_EXTREME_CONTRACTION
79
2026-06-25 Extreme Contraction
US_EXTREME_CONTRACTION
72

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy 0.86 1.10 4.25 3.73
Based on 6 analysts offering recommendations for 'RIGL'.

Quarterly EPS Forecasts

5 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 0.86 0.95 0.76 2
0 1
Jun 2026 1.10 1.20 1.00 2
0 1
Sep 2026 1.13 1.27 0.99 2
0 0
Dec 2026 1.09 1.30 0.87 2
0 0
Mar 2027 0.82 0.82 0.82 1
0 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 4.25 4.73 3.62 3
2 1
Dec 2027 3.73 3.85 3.61 2
0 2
Dec 2028 4.10 4.42 3.77 2
0 0
Dec 2029 4.04 4.04 4.04 1
0 0